Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1058 issues

Do You Qualify for Poteligeo Coverage by UnitedHealthcare in Georgia? Decision Tree & Next Steps

Answer Box: UnitedHealthcare requires prior authorization for Poteligeo (mogamulizumab-kpkc) for relapsed/refractory mycosis fungoides or Sézary syndrome after ≥1 prior systemic therapy. Submit via UHC Provider Portal with staging documentation, prior therapy records, and medical necessity letter from oncologist/dermatologist. If denied, appeal within 180 days or request Georgia external
5 min read

Renewing Acthar Gel Coverage with UnitedHealthcare in New Jersey: Complete Timeline and Documentation Guide

Answer Box: Renewing Acthar Gel with UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization renewal for Acthar Gel, but all reauthorization requests are automatically denied for most conditions—continuation requires appealing to the UHC Pharmacy appeals team. Start your renewal process 2-4 weeks before your current authorization expires to avoid
5 min read

Getting Zanzalintinib (XL092) Covered by UnitedHealthcare in Michigan: Clinical Trials, Compassionate Use, and Appeals Guide 2025

Answer Box: Your Path to Zanzalintinib Access Zanzalintinib (XL092) is an investigational drug not yet FDA-approved. UnitedHealthcare typically denies coverage outside clinical trials. Your fastest path: 1) Search active trials at ClinicalTrials.gov for "XL092" or contact your oncologist about STELLAR program studies, 2) If trial-ineligible, pursue Exelixis
7 min read

How Long Does It Take to Get Elzonris (tagraxofusp-erzs) Approved by UnitedHealthcare in Georgia? Timeline & Appeal Guide

Answer Box: Getting Elzonris Approved by UnitedHealthcare in Georgia Standard timeline: 2-15 business days for prior authorization; 24-72 hours if marked urgent. Fastest path: Submit complete documentation via UnitedHealthcare Provider Portal including CD123-positive BPDCN pathology, CLS monitoring plan, and medical necessity letter. First step today: Verify your exact UnitedHealthcare plan
6 min read

How to Get Haegarda Approved by UnitedHealthcare in Pennsylvania: A Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Haegarda Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Haegarda (C1-esterase inhibitor, SC) in Pennsylvania. To get approval: (1) Ensure your allergist/immunologist documents confirmed HAE diagnosis with low C4 and C1-INH levels, (2) Submit PA through UHC Provider Portal with complete lab results and
6 min read

Complete Guide to Getting Keppra (Levetiracetam) Covered by UnitedHealthcare in North Carolina: Forms, Appeals, and Medical Necessity Requirements

Answer Box: Fast Track to Keppra Coverage Generic levetiracetam typically requires no prior authorization on UnitedHealthcare plans, while brand Keppra needs PA with documented 4-week generic trial failure. Submit via UHC Provider Portal with seizure logs, prior medication failures, and medical necessity letter. Standard review takes 3-5 business days; expedited
7 min read

UnitedHealthcare's Coverage Criteria for Tagrisso (osimertinib) in Pennsylvania: What Counts as "Medically Necessary"?

Answer Box: Getting Tagrisso Covered by UnitedHealthcare in Pennsylvania To get Tagrisso (osimertinib) covered by UnitedHealthcare in Pennsylvania, you need: documented EGFR mutation (exon 19 deletion or L858R), confirmed NSCLC diagnosis, and prior authorization approval. Submit through the UHC Provider Portal with pathology reports and staging documentation. If denied, Pennsylvania&
5 min read

How to Get Stelara (Ustekinumab) Covered by UnitedHealthcare in Illinois: Complete 2025 Guide to Prior Authorization, Appeals, and Biosimilar Requirements

Answer Box: Getting Stelara Covered by UnitedHealthcare in Illinois UnitedHealthcare requires prior authorization for Stelara (ustekinumab) in Illinois, with most commercial plans now requiring biosimilar trials first. As of 2025, brand Stelara is non-formulary; patients must try Steqeyma or Yesintek unless documenting allergy/intolerance or clinical failure after 6+ weeks
6 min read